The deal has a value of up to $330 million, with the final price tied to future sales of Optinose's flagship product.

UnitedHealth Group has been a reliable megacap for years. Its sudden decline in recent months is raising questions about the future fate of its stock.

UnitedHealth Group investors, stunned by missteps at the once predictable healthcare giant, are warily expecting strategic ...

UnitedHealth Group stock was sliding again Thursday as the market took in a report in the Wall Street Journal that the U.S.

UnitedHealth Group stock has plummeted since my last Buy rating and is ~55% off highs, but its lower valuation now offers a ...

Former UnitedHealth Group chief executive officer Stephen Hemsley to replace Andrew Witty. Here's what we know.

UnitedHealth Group's stock has collapsed nearly 50% in 2025 after a leadership shake-up, surging medical costs, and a DOJ ...

UnitedHealth Group Inc. on May 13 issued an update with two items of notable news, saying that its medical costs are likely ...

Stephen Hemsley ran UnitedHealth Group for more than a decade. It's a different company after four years with Andrew Witty in ...

Andrew Witty’s resignation, announced abruptly, stunned investors and employees. UnitedHealth stated that Witty stepped down ...

Shares of UnitedHealth Group, Inc. (UNH) fell over 17% on Tuesday after the health insurance giant said CEO Andrew Witty ...

The nation's largest health insurer suspended its full-year financial outlook due to higher-than-expected medical costs.